Involvement of Lysophospholipids in Pulmonary Vascular Functions and Diseases

Involvement of Lysophospholipids in Pulmonary Vascular Functions and Diseases

Extracellular lysophospholipids (lysophosphatidic acid, lysophosphatidylcholine, sphingosine 1-phosphate, etc.), which are synthesized from phospholipids in the cell membrane, act as lipid mediators, and mediate various cellular responses in constituent cells in the respiratory system, such as contr...

Full description

Bibliographic Details
Main Authors:	Hiroaki Kume, Rina Harigane, Mami Rikimaru
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Biomedicines
Subjects:	lysophosphatidic acid lysophosphadidylcholine sphingosine 1-phosphate pulmonary vascular smooth muscle pulmonary endothelial cells pulmonary fibroblasts
Online Access:	https://www.mdpi.com/2227-9059/12/1/124

Similar Items

The Role of Sphingolipids in Regulating Vascular Permeability in Idiopathic Pulmonary Fibrosis
by: Girish Jayant, et al.
Published: (2023-06-01)

The Role of Regulatory T Cells in Pulmonary Arterial Hypertension
by: Haihua Qiu, et al.
Published: (2019-12-01)

Mechanosensitivity in Pulmonary Circulation: Pathophysiological Relevance of Stretch-Activated Channels in Pulmonary Hypertension
by: Solène Barbeau, et al.
Published: (2021-09-01)

Transcription factors and potential therapeutic targets for pulmonary hypertension
by: Liu Yang, et al.
Published: (2023-03-01)

Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling
by: Xiaowei Nie, et al.
Published: (2021-11-01)

Overexpression of Msx1 in Mouse Lung Leads to Loss of Pulmonary Vessels Following Vascular Hypoxic Injury
by: James West, et al.
Published: (2021-09-01)

Extracellular vesicles derived from endothelial cells in hypoxia contribute to pulmonary artery smooth muscle cell proliferation in‐vitro and pulmonary hypertension in mice
by: Tianji Chen, et al.
Published: (2022-01-01)

S100A4+ Macrophages Are Necessary for Pulmonary Fibrosis by Activating Lung Fibroblasts
by: Yanan Li, et al.
Published: (2018-08-01)

Aloperine suppresses human pulmonary vascular smooth muscle cell proliferation via inhibiting inflammatory response
by: Zhi Chang, et al.
Published: (2019-01-01)

Preventive treatment with ginsenoside Rb1 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats and involves store-operated calcium entry inhibition
by: Rui-Xing Wang, et al.
Published: (2020-01-01)

Characterization of proximal pulmonary arterial cells from chronic thromboembolic pulmonary hypertension patients
by: Quarck Rozenn, et al.
Published: (2012-03-01)

The Platelet-Derived Growth Factor Pathway in Pulmonary Arterial Hypertension: Still an Interesting Target?
by: Julien Solinc, et al.
Published: (2022-04-01)

Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review
by: Lidan Cui, et al.
Published: (2022-07-01)

Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment
by: Yan Xu
Published: (2018-07-01)

Editorial: Pathophysiology and Pathogenic Mechanisms of Pulmonary Vascular Disease
by: Jinsheng Zhu, et al.
Published: (2022-03-01)

Commentary: Sphingosine-1-phosphate inhibitors are potential therapeutic targets for pulmonary arterial hypertension
by: Naga P Bhavanam, et al.
Published: (2015-10-01)

Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension
by: France Dierick, et al.
Published: (2021-05-01)

Entering, Linked with the Sphinx: Lysophosphatidic Acids Everywhere, All at Once, in the Oral System and Cancer
by: D. Roselyn Cerutis, et al.
Published: (2023-06-01)

<i>Yarsagumba</i> is a Promising Therapeutic Option for Treatment of Pulmonary Hypertension due to the Potent Anti-Proliferative and Vasorelaxant Properties
by: Himal Luitel, et al.
Published: (2020-03-01)

IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis
by: Javier Milara, et al.
Published: (2022-11-01)

RhoGTPase in Vascular Disease
by: Derek Strassheim, et al.
Published: (2019-06-01)

Lipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways
by: Vidyani Suryadevara, et al.
Published: (2020-06-01)

Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis
by: Adnot Serge, et al.
Published: (2002-01-01)

Hypoxia enhances interactions between Na+/H+ exchanger isoform 1 and actin filaments via ezrin in pulmonary vascular smooth muscle
by: Julie M. Lade, et al.
Published: (2023-02-01)

CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cells
by: Weimin Yu, et al.
Published: (2023-12-01)

Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis
by: Steven D. Nathan, et al.
Published: (2024-01-01)

Traditional Chinese medicine monomers: Targeting pulmonary artery smooth muscle cells proliferation to treat pulmonary hypertension
by: Xiuli Yang, et al.
Published: (2023-04-01)

Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1
by: Sharon Mumby, et al.
Published: (2023-07-01)

Differential Regulation of Lung Endothelial Permeability in Vitro and in Situ
by: Stefan Uhlig, et al.
Published: (2014-06-01)

Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling
by: Liu J, et al.
Published: (2024-03-01)

Upregulation of Aquaporin 1 Mediates Increased Migration and Proliferation in Pulmonary Vascular Cells From the Rat SU5416/Hypoxia Model of Pulmonary Hypertension
by: Xin Yun, et al.
Published: (2021-12-01)

Deletion of classical transient receptor potential 1, 3 and 6 alters pulmonary vasoconstriction in chronic hypoxia-induced pulmonary hypertension in mice
by: Kathrin Malkmus, et al.
Published: (2022-12-01)

Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension
by: Khushboo Goel, et al.
Published: (2022-12-01)

Inhibition of microRNA-30a alleviates vascular remodeling in pulmonary arterial hypertension
by: Wenrui Ma, et al.
Published: (2021-12-01)

Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension
by: Jingjing Zhou, et al.
Published: (2022-08-01)

Pulmonary Embolism and vascular injury: What is the role of thrombin?
by: Filip A Konecny
Published: (2007-08-01)

Salusin-β, a TOR2A gene product, promotes proliferation, migration, fibrosis, and calcification of smooth muscle cells and accelerates the imbalance of vasomotor function and vascular remodeling in monocrotaline-induced pulmonary hypertensive rats
by: Xingxing Wang, et al.
Published: (2022-09-01)

Galectin-3- Mediated Transdifferentiation of Pulmonary Artery Endothelial Cells Contributes to Hypoxic Pulmonary Vascular Remodeling
by: Li Zhang, et al.
Published: (2018-11-01)

Increased Methyl-CpG-Binding Domain Protein 2 Promotes Cigarette Smoke-Induced Pulmonary Hypertension
by: Jixing Wu, et al.
Published: (2022-06-01)

S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung
by: Mengyao Hao, et al.
Published: (2023-03-01)